Compare Moderna, Inc. (MRNA) vs Workiva Inc (WK) Price & Performance

Moderna, Inc.Trade

Workiva IncTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Workiva Inc — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while Workiva Inc trades at $55.02 (market cap $3.21B). The key difference: Moderna, Inc. is far larger — about 7.4× Workiva Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Workiva Inc nearer its low. Which is the better fit depends on your goals.

	MRNA	WK
Market Cap	$23.60B	$3.21B
Sector	Health	Technology
52-Week High	$81.80	$93.31
52-Week Low	$22.36	$44.31
Enterprise Value	$19.70B	$3.14B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 13 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About Workiva Inc

Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.